Medical Properties Trust's EBIT per Share for the
three
months ended in Mar. 2026 was €0.19.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €0.57.
During the past 12 months, the average EBIT per Share Growth Rate of Medical Properties Trust was 67.70% per year.
During the past 3 years, the average EBIT per Share Growth Rate was -18.80% per year.
During the past 5 years, the average EBIT per Share Growth Rate was -21.10% per year.
During the past 10 years, the average EBIT per Share Growth Rate was -10.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Medical Properties Trust's EBIT per Share or its related term are showing as below:
FRA:M3P'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -55.7 Med: 4.5 Max: 57.7
Current: -18.8
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Medical Properties Trust was 57.70% per year. The lowest was -55.70% per year. And the median was 4.50% per year.
FRA:M3P's 3-Year EBIT Growth Rate is ranked worse than 93.03% of 660
companies
in the REITs industry
Industry Median: 3.4
vs FRA:M3P: -18.80
Medical Properties Trust (FRA:M3P) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Medical Properties Trust EBIT per Share Related Terms
Medical Properties Trust EBIT per Share Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.57
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Medical Properties Trust (FRA:M3P) has a EBIT per Share of €0.57 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Properties Trust and its competitors. According to the industry distribution chart, Medical Properties Trust ranks #614 out of 660 companies in the REITs industry, placing it in the top 93%.
Is Medical Properties Trust's EBIT per Share too high?
Medical Properties Trust's current EBIT per Share is €0.57. Based on the distribution chart, Medical Properties Trust ranks #614 out of 660 companies in the REITs industry, which is in the bottom quartile relative to peers. Overall, Medical Properties Trust has a GF Score™ of 64/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medical Properties Trust's EBIT per Share compare to DHC and LTC?
According to the REITs industry distribution chart, Medical Properties Trust ranks #614 out of 660 companies for EBIT per Share. This places Medical Properties Trust in the lower half of its industry. The industry median EBIT per Share is 3.40. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a REITs company?
The median EBIT per Share among REITs companies is 3.40, based on 660 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Medical Properties Trust and its competitors. For the REITs industry, the median EBIT per Share is 3.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medical Properties Trust's current EBIT per Share is €0.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medical Properties Trust stock overvalued right now?
Based on GuruFocus' analysis, Medical Properties Trust (FRA:M3P) is currently considered Modestly Undervalued. The stock's GF Value™ is €4.65, compared to a current price of €4.00 — trading 13.9% below its estimated fair value. The current EBIT per Share is €0.57. Medical Properties Trust's overall GF Score™ is 64/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Medical Properties Trust (FRA:M3P), the current EBIT per Share is €0.57 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Medical Properties Trust (FRA:M3P) Overvalued in 2026?
Based on GuruFocus' analysis, Medical Properties Trust stock appears to be undervalued.
The current stock price of €4.00 is trading 13.9% below its estimated GF Value™ of €4.65.
GuruFocus considers Medical Properties Trust to be Modestly Undervalued.
Key valuation signals for FRA:M3P:
EBIT per Share: €0.57
GF Value™: €4.65 vs. price of €4.00 (13.9% below fair value)
No single metric tells the full story. See the FRA:M3P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Medical Properties Trust Inc acquires and develops net-leased healthcare facilities. Its investments in healthcare real estate, other loans, and any investments in tenants are considered a single reportable segment. Its business strategy is to acquire and develop healthcare facilities and lease the facilities to healthcare operating companies under long-term net leases, which require the tenant to bear of the costs associated with the property. The group's geographic areas are the United States, the United Kingdom, and All other countries.
64GF Score
Get the complete analysis for FRA:M3P
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3P has been successfully added to your 
